Hyseq Pharmaceuticals, Inc. is engaged in research and development of novel biopharmaceutical products from its collection of proprietary genes discovered using its high-throughput screening-by-hybridization platform. This platform provided a significant advantage in discovering novel, rarely- expressed genes, and assembly of one of the most important proprietary databases of full-length human gene sequences. Hyseq intends to further elucidate the physiological roles of its proprietary novel genes. Hyseq's database includes genes which encode a number of therapeutically important classes of molecules including chemokines, growth factors, stem cell factors, interferons, integrins, proteases, hormones, receptors, and other potential protein therapeutics or drug targets.
| Website | http://www.hyseq.com |
| Revenue | $14 million |
| Employees | View employees |
| Address | 670 Almanor Ave, Sunnyvale, California 94085, US |
| Phone | +1 408-524-8100 |
| Industry | Biotechnology, Pharmaceuticals, Healthcare |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Myriad Genetics, PacBio, Genomic Health +42 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Hyseq , Inc. employee's phone or email?
Hyseq , Inc. Questions
The Hyseq , Inc. annual revenue was $14 million in 2026.
Hyseq , Inc. is based in Sunnyvale, California.
The NAICS codes for Hyseq , Inc. are [3254, 32, 325].
The SIC codes for Hyseq , Inc. are [283, 28, 80].
